CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia
Latest Information Update: 21 Sep 2023
At a glance
- Drugs Anti CD19 chimeric antigen receptor T cell therapy Union Stem Cell and Gene Engineering (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Sponsors Zhongyuan Union Stem Cell Bio-engineering Corporation
- 04 Mar 2019 Status changed from recruiting to completed.
- 02 Dec 2016 New trial record